Sarah Turner is a clinical neuroscientist with post-graduate degrees from Roehampton University, London, and BSc degrees in Psychological Sciences and Nutritional Medicine from Westminster University and Thames Valley University. She is currently pursuing a diploma in Photobiomodulation at the University of Montpellier in France.

She has a keen interest in quantum biology specifically in health, photomedicine, and consciousness studies. Sarah's primary focus lies in photobiomodulation, which involves utilizing specific light wavelengths and pulsed frequencies to enhance optimal functioning, with a specific emphasis on brain-related issues.

Sarah's company, Cerathrive, is home of the cutting-edge neurotechnology. Her groundbreaking system is a combination of two red light therapy devices that target the gut-brain axis for optimized brain function, increased longevity, and peak physiological health. This is the only FDA-listed red light therapy system of its kind, Cerathrive's technology is set to revolutionize the way we approach brain health.